secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anixa Biosciences Inc (ANIX)
CIK:        0000715446
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001493152-23-007172
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anixa Biosciences stockholders re-elect four directors, approve say-on-pay, ratify auditor
--------------------------------------------------------------------------------

- Re-elected Dr. Amit Kumar (10.26M for, 940k withheld), Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton Jr.
- Non-binding advisory vote on executive compensation passed: 9.17M for, 1.82M against, 221k abstain.
- Ratified Haskell & White LLP as auditor for FY ending Oct 31, 2023: 20.44M for, 61k against.
- Annual meeting held March 9, 2023; 20.97M shares represented out of 30.92M outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/715446/000149315223007172/0001493152-23-007172-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/715446/000149315223007172/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-007172

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer